Rein Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Rein Therapeutics, Inc. (RNTX) reported Earnings Per Share, Basic and Diluted of -$0.09 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- Rein Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.09.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.07.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.06.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.08.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.29.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.61.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.20.
- Rein Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$2.14.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.09 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$0.29 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$0.07 10-Q · filed 2021-11-12 | -$0.22 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | -$0.06 10-Q · filed 2021-08-11 | -$0.15 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | -$0.08 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$0.12 10-K · filed 2021-03-24 | -$0.61 10-K · filed 2022-03-28 | ||
| 2020-09-30 | -$0.13 10-Q · filed 2021-11-12 | -$0.49 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.14 10-Q · filed 2021-08-11 | -$0.38 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$0.24 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | -$0.26 10-K · filed 2021-03-24 | -$1.20 10-K · filed 2021-03-24 | ||
| 2019-09-30 | -$0.28 10-K · filed 2021-03-24 | -$0.95 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$0.26 10-K · filed 2021-03-24 | -$0.68 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | -$0.49 10-K · filed 2021-03-24 | |||
| 2018-12-31 | -$0.48 10-K · filed 2020-03-30 | -$0.98 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$1.63 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$2.14 10-K · filed 2020-03-30 |
| 2018-09-30 | -$0.50 10-K · filed 2020-03-30 | -$1.15 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$1.66 10-Q · filed 2019-11-07 | -$2.13 derived: net income ÷ weighted average shares · filed 2020-03-30 |
| 2018-06-30 | -$0.64 10-K · filed 2020-03-30 | -$1.16 10-Q · filed 2019-08-06 | -$1.63 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$2.08 derived: net income ÷ weighted average shares · filed 2020-03-30 |
| 2018-03-31 | -$0.52 10-K · filed 2020-03-30 | -$0.98 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$1.43 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$2.34 derived: net income ÷ weighted average shares · filed 2020-03-30 |
| 2017-12-31 | -$0.47 10-K · filed 2019-03-29 | -$0.92 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$1.86 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$3.04 10-K · filed 2019-03-29 |
| 2017-09-30 | -$0.45 10-K · filed 2019-03-29 | -$1.56 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$3.16 10-Q · filed 2018-11-07 | -$5.31 derived: net income ÷ weighted average shares · filed 2019-03-29 |
| 2017-06-30 | -$10.98 10-K · filed 2019-03-29 | -$21.56 10-Q · filed 2018-08-07 | -$31.88 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$41.73 derived: net income ÷ weighted average shares · filed 2019-03-29 |
| 2017-03-31 | -$10.58 10-K · filed 2019-03-29 | -$20.89 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$30.74 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$43.67 derived: net income ÷ weighted average shares · filed 2019-03-29 |
| 2016-12-31 | -$10.31 10-K · filed 2018-04-02 | -$20.16 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$33.09 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$42.35 10-K · filed 2018-04-02 |
| 2016-09-30 | -$9.84 10-K · filed 2018-04-02 | -$22.78 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$32.04 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$12.95 10-K · filed 2018-04-02 | -$22.21 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$9.25 10-K · filed 2018-04-02 | |||
| 2015-12-31 | -$32.31 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |